Click for best price
Melanoma Skin Cancer Diagnostic Testing Market Size, Share 2023
Melanoma skin cancer is the most dangerous type of skin cancer. Development of defective DNA due to exposure to the ultraviolet radiation from sunlight or tanning beds leads to develop melanoma skin cancer. This genetic defect triggers mutation in the cell structure resulting in rapid multiplication of cells forming a malignant tumor. These malignant tumors often originate at basal layer of epidermis which produces melanocyte type of pigment which makes most of melanoma skin cancer black or brown in color. As per skin cancer foundation, in 2018 around 178,560 cases of melanoma will be diagnosed in United States alone. Melanoma skin cancer is the least common type of skin cancer and it is curable if diagnosed early. Early melanoma skin cancer diagnostic testing plays major role future treatment regimen and possible cure for the patient.
This report aims to provide a comprehensive presentation of the global market for Melanoma Skin Cancer Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Melanoma Skin Cancer Diagnostic Testing. This report contains market size and forecasts of Melanoma Skin Cancer Diagnostic Testing in global, including the following market information:
Global Melanoma Skin Cancer Diagnostic Testing Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Melanoma Skin Cancer Diagnostic Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Biopsy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Melanoma Skin Cancer Diagnostic Testing include Myriad Genetics, Abbott Laboratories, Foundation Medicine, Pathway Genomics Corporation, Cancer Genetics, Castle Biosciences, NeoGenomics, Dermtech and Sysmex Inostics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Melanoma Skin Cancer Diagnostic Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Melanoma Skin Cancer Diagnostic Testing Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Melanoma Skin Cancer Diagnostic Testing Market Segment Percentages, by Type, 2022 (%)
Biopsy
Imaging
Others
Global Melanoma Skin Cancer Diagnostic Testing Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Melanoma Skin Cancer Diagnostic Testing Market Segment Percentages, by Application, 2022 (%)
Hospitals
Dermatology Clinics
Diagnostic Laboratories
Others
Global Melanoma Skin Cancer Diagnostic Testing Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Melanoma Skin Cancer Diagnostic Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Melanoma Skin Cancer Diagnostic Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Melanoma Skin Cancer Diagnostic Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Myriad Genetics
Abbott Laboratories
Foundation Medicine
Pathway Genomics Corporation
Cancer Genetics
Castle Biosciences
NeoGenomics
Dermtech
Sysmex Inostics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Melanoma Skin Cancer Diagnostic Testing, market overview.
Chapter 2: Global Melanoma Skin Cancer Diagnostic Testing market size in revenue.
Chapter 3: Detailed analysis of Melanoma Skin Cancer Diagnostic Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Melanoma Skin Cancer Diagnostic Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Melanoma Skin Cancer Diagnostic Testing Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Melanoma Skin Cancer Diagnostic Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Melanoma Skin Cancer Diagnostic Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Melanoma Skin Cancer Diagnostic Testing Overall Market Size
2.1 Global Melanoma Skin Cancer Diagnostic Testing Market Size: 2022 VS 2030
2.2 Global Melanoma Skin Cancer Diagnostic Testing Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Melanoma Skin Cancer Diagnostic Testing Players in Global Market
3.2 Top Global Melanoma Skin Cancer Diagnostic Testing Companies Ranked by Revenue
3.3 Global Melanoma Skin Cancer Diagnostic Testing Revenue by Companies
3.4 Top 3 and Top 5 Melanoma Skin Cancer Diagnostic Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Melanoma Skin Cancer Diagnostic Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Melanoma Skin Cancer Diagnostic Testing Players in Global Market
3.6.1 List of Global Tier 1 Melanoma Skin Cancer Diagnostic Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Melanoma Skin Cancer Diagnostic Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Melanoma Skin Cancer Diagnostic Testing Market Size Markets, 2022 & 2030
4.1.2 Biopsy
4.1.3 Imaging
4.1.4 Others
4.2 By Type - Global Melanoma Skin Cancer Diagnostic Testing Revenue & Forecasts
4.2.1 By Type - Global Melanoma Skin Cancer Diagnostic Testing Revenue, 2018-2023
4.2.2 By Type - Global Melanoma Skin Cancer Diagnostic Testing Revenue, 2024-2030
4.2.3 By Type - Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Melanoma Skin Cancer Diagnostic Testing Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Dermatology Clinics
5.1.4 Diagnostic Laboratories
5.1.5 Others
5.2 By Application - Global Melanoma Skin Cancer Diagnostic Testing Revenue & Forecasts
5.2.1 By Application - Global Melanoma Skin Cancer Diagnostic Testing Revenue, 2018-2023
5.2.2 By Application - Global Melanoma Skin Cancer Diagnostic Testing Revenue, 2024-2030
5.2.3 By Application - Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Melanoma Skin Cancer Diagnostic Testing Market Size, 2022 & 2030
6.2 By Region - Global Melanoma Skin Cancer Diagnostic Testing Revenue & Forecasts
6.2.1 By Region - Global Melanoma Skin Cancer Diagnostic Testing Revenue, 2018-2023
6.2.2 By Region - Global Melanoma Skin Cancer Diagnostic Testing Revenue, 2024-2030
6.2.3 By Region - Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Melanoma Skin Cancer Diagnostic Testing Revenue, 2018-2030
6.3.2 US Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.3.3 Canada Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.3.4 Mexico Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Melanoma Skin Cancer Diagnostic Testing Revenue, 2018-2030
6.4.2 Germany Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.4.3 France Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.4.4 U.K. Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.4.5 Italy Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.4.6 Russia Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.4.7 Nordic Countries Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.4.8 Benelux Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Melanoma Skin Cancer Diagnostic Testing Revenue, 2018-2030
6.5.2 China Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.5.3 Japan Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.5.4 South Korea Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.5.5 Southeast Asia Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.5.6 India Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Melanoma Skin Cancer Diagnostic Testing Revenue, 2018-2030
6.6.2 Brazil Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.6.3 Argentina Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue, 2018-2030
6.7.2 Turkey Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.7.3 Israel Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.7.4 Saudi Arabia Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
6.7.5 UAE Melanoma Skin Cancer Diagnostic Testing Market Size, 2018-2030
7 Melanoma Skin Cancer Diagnostic Testing Companies Profiles
7.1 Myriad Genetics
7.1.1 Myriad Genetics Company Summary
7.1.2 Myriad Genetics Business Overview
7.1.3 Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Major Product Offerings
7.1.4 Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Revenue in Global Market (2018-2023)
7.1.5 Myriad Genetics Key News & Latest Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Major Product Offerings
7.2.4 Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Revenue in Global Market (2018-2023)
7.2.5 Abbott Laboratories Key News & Latest Developments
7.3 Foundation Medicine
7.3.1 Foundation Medicine Company Summary
7.3.2 Foundation Medicine Business Overview
7.3.3 Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Major Product Offerings
7.3.4 Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Revenue in Global Market (2018-2023)
7.3.5 Foundation Medicine Key News & Latest Developments
7.4 Pathway Genomics Corporation
7.4.1 Pathway Genomics Corporation Company Summary
7.4.2 Pathway Genomics Corporation Business Overview
7.4.3 Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Major Product Offerings
7.4.4 Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Revenue in Global Market (2018-2023)
7.4.5 Pathway Genomics Corporation Key News & Latest Developments
7.5 Cancer Genetics
7.5.1 Cancer Genetics Company Summary
7.5.2 Cancer Genetics Business Overview
7.5.3 Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Major Product Offerings
7.5.4 Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Revenue in Global Market (2018-2023)
7.5.5 Cancer Genetics Key News & Latest Developments
7.6 Castle Biosciences
7.6.1 Castle Biosciences Company Summary
7.6.2 Castle Biosciences Business Overview
7.6.3 Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Major Product Offerings
7.6.4 Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Revenue in Global Market (2018-2023)
7.6.5 Castle Biosciences Key News & Latest Developments
7.7 NeoGenomics
7.7.1 NeoGenomics Company Summary
7.7.2 NeoGenomics Business Overview
7.7.3 NeoGenomics Melanoma Skin Cancer Diagnostic Testing Major Product Offerings
7.7.4 NeoGenomics Melanoma Skin Cancer Diagnostic Testing Revenue in Global Market (2018-2023)
7.7.5 NeoGenomics Key News & Latest Developments
7.8 Dermtech
7.8.1 Dermtech Company Summary
7.8.2 Dermtech Business Overview
7.8.3 Dermtech Melanoma Skin Cancer Diagnostic Testing Major Product Offerings
7.8.4 Dermtech Melanoma Skin Cancer Diagnostic Testing Revenue in Global Market (2018-2023)
7.8.5 Dermtech Key News & Latest Developments
7.9 Sysmex Inostics
7.9.1 Sysmex Inostics Company Summary
7.9.2 Sysmex Inostics Business Overview
7.9.3 Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Major Product Offerings
7.9.4 Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Revenue in Global Market (2018-2023)
7.9.5 Sysmex Inostics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Melanoma Skin Cancer Diagnostic Testing Market Opportunities & Trends in Global Market
Table 2. Melanoma Skin Cancer Diagnostic Testing Market Drivers in Global Market
Table 3. Melanoma Skin Cancer Diagnostic Testing Market Restraints in Global Market
Table 4. Key Players of Melanoma Skin Cancer Diagnostic Testing in Global Market
Table 5. Top Melanoma Skin Cancer Diagnostic Testing Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Melanoma Skin Cancer Diagnostic Testing Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Melanoma Skin Cancer Diagnostic Testing Revenue Share by Companies, 2018-2023
Table 8. Global Companies Melanoma Skin Cancer Diagnostic Testing Product Type
Table 9. List of Global Tier 1 Melanoma Skin Cancer Diagnostic Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Melanoma Skin Cancer Diagnostic Testing Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Melanoma Skin Cancer Diagnostic Testing Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Melanoma Skin Cancer Diagnostic Testing Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Melanoma Skin Cancer Diagnostic Testing Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Melanoma Skin Cancer Diagnostic Testing Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2024-2030
Table 30. Myriad Genetics Company Summary
Table 31. Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Product Offerings
Table 32. Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn) & (2018-2023)
Table 33. Myriad Genetics Key News & Latest Developments
Table 34. Abbott Laboratories Company Summary
Table 35. Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Product Offerings
Table 36. Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn) & (2018-2023)
Table 37. Abbott Laboratories Key News & Latest Developments
Table 38. Foundation Medicine Company Summary
Table 39. Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Product Offerings
Table 40. Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn) & (2018-2023)
Table 41. Foundation Medicine Key News & Latest Developments
Table 42. Pathway Genomics Corporation Company Summary
Table 43. Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Product Offerings
Table 44. Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn) & (2018-2023)
Table 45. Pathway Genomics Corporation Key News & Latest Developments
Table 46. Cancer Genetics Company Summary
Table 47. Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Product Offerings
Table 48. Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn) & (2018-2023)
Table 49. Cancer Genetics Key News & Latest Developments
Table 50. Castle Biosciences Company Summary
Table 51. Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Product Offerings
Table 52. Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn) & (2018-2023)
Table 53. Castle Biosciences Key News & Latest Developments
Table 54. NeoGenomics Company Summary
Table 55. NeoGenomics Melanoma Skin Cancer Diagnostic Testing Product Offerings
Table 56. NeoGenomics Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn) & (2018-2023)
Table 57. NeoGenomics Key News & Latest Developments
Table 58. Dermtech Company Summary
Table 59. Dermtech Melanoma Skin Cancer Diagnostic Testing Product Offerings
Table 60. Dermtech Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn) & (2018-2023)
Table 61. Dermtech Key News & Latest Developments
Table 62. Sysmex Inostics Company Summary
Table 63. Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Product Offerings
Table 64. Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Revenue (US$, Mn) & (2018-2023)
Table 65. Sysmex Inostics Key News & Latest Developments
List of Figures
Figure 1. Melanoma Skin Cancer Diagnostic Testing Segment by Type in 2022
Figure 2. Melanoma Skin Cancer Diagnostic Testing Segment by Application in 2022
Figure 3. Global Melanoma Skin Cancer Diagnostic Testing Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Melanoma Skin Cancer Diagnostic Testing Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Melanoma Skin Cancer Diagnostic Testing Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Melanoma Skin Cancer Diagnostic Testing Revenue in 2022
Figure 8. By Type - Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2018-2030
Figure 9. By Application - Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2018-2030
Figure 10. By Type - Global Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2018-2030
Figure 12. By Application - Global Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2018-2030
Figure 14. By Region - Global Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2018-2030
Figure 15. By Country - North America Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2018-2030
Figure 16. US Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2018-2030
Figure 20. Germany Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 21. France Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2018-2030
Figure 28. China Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 32. India Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2018-2030
Figure 34. Brazil Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Melanoma Skin Cancer Diagnostic Testing Revenue Market Share, 2018-2030
Figure 37. Turkey Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Melanoma Skin Cancer Diagnostic Testing Revenue, (US$, Mn), 2018-2030
Figure 41. Myriad Genetics Melanoma Skin Cancer Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbott Laboratories Melanoma Skin Cancer Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Foundation Medicine Melanoma Skin Cancer Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pathway Genomics Corporation Melanoma Skin Cancer Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Cancer Genetics Melanoma Skin Cancer Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Castle Biosciences Melanoma Skin Cancer Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. NeoGenomics Melanoma Skin Cancer Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Dermtech Melanoma Skin Cancer Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Sysmex Inostics Melanoma Skin Cancer Diagnostic Testing Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
